In addition, our data implied that the mutation of ANGPTL2 decreases the release of ANGPTL2-SEVs, which leads to the reduced effect of ANGPTL2 on enhancing B-ALL development. This evidence concerns the gene ANGPTL2 and precursor B-cell acute lymphoblastic leukemia.